CARSON-TAHOE PATHOLOGY DRS JACK & DOBERNECK LTD SOS Verified
1600 MEDICAL PKWY, CARSON CITY, NV 89703
NPI Number
1104971183
SOS Verification: Verified
Entity Name: CARSON TAHOE ENDOCRINOLOGY, LLC
Entity Number: LLC11154-2003
Entity Type: Domestic Limited-Liability Company
Entity Status: Active
Formation Date: 2003-07-25
Status Changed: 2015-09-16
Name Match: 80%
Registered Agent
Name: ALLISON MACKENZIE, LTD.
Type: Commercial Registered Agent
Address: 402 NORTH DIVISION STREET, Carson City, NV, 89703
Officers / Principals
| Title | Name | Address | Status |
|---|---|---|---|
| Manager | JOHN SUTTON D O | 1177 N DIVISION ST #3, CARSON CITY, NV, 89703 | Active |
Total Medicaid Payments
$42,058
-99% vs specialty average
Patients Seen
1,979
Total Claims
2,362
$ Per Patient
$21
Specialty avg: $9
Specialty Rank
#23 of 34
Clinical Medical Laboratory providers in Nevada
Peer Average
$3,969,875
Average total for Clinical Medical Laboratory
Claims per Patient
1.2
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $10,062 | |
| 2019 | $8,740 | |
| 2020 | $6,406 | |
| 2021 | $9,425 | |
| 2022 | $5,689 | |
| 2023 | $1,735 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 88305 | Tissue examination under a microscope (surgical pathology) | 2,316 | $41,845 | 99.5% | $18 |
| 88304 | Tissue examination under a microscope (surgical pathology) | 46 | $213 | 0.5% | $5 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.